Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset.
about
Language performance in Alzheimer's disease and mild cognitive impairment: A comparative reviewThe Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriersUshering in the study and treatment of preclinical Alzheimer diseaseImprovement of Screening Accuracy of Mini-Mental State Examination for Mild Cognitive Impairment and Non-Alzheimer's Disease Dementia by Supplementation of Verbal Fluency PerformancePrediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.Longitudinal verbal fluency in normal aging, preclinical, and prevalent Alzheimer's disease[Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].Impaired generation of new subcategories and switching in a semantic verbal fluency test in older adults with mild cognitive impairment.Lexical retrieval in discourse: an early indicator of Alzheimer's dementia.Graph analysis of verbal fluency test discriminate between patients with Alzheimer's disease, mild cognitive impairment and normal elderly controls.Robust and expanded norms for the Dementia Rating ScalePerforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-oldChanges in cognition.Normative data in women aged 85 and older: verbal fluency, digit span, and the CVLT-II short formCognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.The Extension of the German CERAD Neuropsychological Assessment Battery with Tests Assessing Subcortical, Executive and Frontal Functions Improves Accuracy in Dementia Diagnosis.An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease.Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.Brain aging, Alzheimer's disease, and mitochondria.Evolution of the diagnostic criteria for degenerative and cognitive disorders.Hormone replacement therapy and risk for neurodegenerative diseases.Empirically Derived Trajectories to Dementia Over 15 Years of Follow-up Identified by Using Mixed Membership Models.Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognitionDendritic BC200 RNA in aging and in Alzheimer's disease.Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review.Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study.Anemia and 9-year domain-specific cognitive decline in community-dwelling older women: The Women's Health and Aging Study II.Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.The elephant in the room - healthy brains in later life, epidemiology and public health.Diagnostic criteria of dementia.A behavioral task predicts conversion to mild cognitive impairment and Alzheimer's disease.Molecular markers of neuropsychological functioning and Alzheimer's disease.Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning.The neuropsychology of normal aging and preclinical Alzheimer's diseaseThe 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and ChallengesSubjective memory complaints and concurrent memory performance in older patients of primary care providers.
P2860
Q22248003-A509D2CE-608B-49E0-8B96-3F7D5C09EA4DQ26849380-3DC2C564-7B3F-4A45-B2C9-A2F83B271C55Q27014791-75CD8BB6-334E-40EE-98FA-72E49CC65EB9Q28658204-FCE3768F-D506-4B12-80D3-F3A2B743D447Q30996721-0CC99B66-FEC9-4E63-BA2C-A53BDBD0F022Q33666725-97C444C7-DBE6-42F0-93FF-3CEDF755BDC8Q33789963-63922F71-786F-40D0-862C-AD4EC2C6B166Q33827449-B30B4382-38A1-42B3-BBAB-04AE7FEB7EEAQ33893311-D2123079-4E84-4BE4-A223-EC46685C365DQ33965567-F8BAB249-480D-43A4-8506-E0A4732FEB5FQ33997680-8FB37F51-4CA1-4BED-90F9-FAD2006A9894Q34044073-4F98AAF6-730C-4DED-BB7F-22E6E2094A6CQ34073106-DD4ACEE2-CF3D-4ECE-B789-DA446ABDAA57Q34120359-F795A5D4-68F4-45DF-BE03-7676E63F393FQ34180413-5F1CCB85-0903-4244-857A-A5A6451A1626Q34250070-F4D4451E-EB8D-4FA8-8B96-7A02CE8EE74CQ34364368-8A882137-6D72-4CA5-AEE3-59FAFE500352Q34570703-0A20B248-08A0-4C80-96C3-6E25EFF5F7EBQ35043616-47D11372-B986-43BA-BB18-BAB010D004B9Q35048396-E5D142EE-4BE0-4E55-A6B5-5B949AE5B6BBQ35394390-7478F25D-DE1B-47C2-8A5B-32EE2CF4242CQ35533354-234E76B8-909E-4303-B5B7-B27830595B8EQ35708394-539F2F06-47A7-44CA-9C71-5C7ADB03C0DFQ35884815-9984728E-F6C9-4434-824F-5B904FDE0480Q35927794-DCA2336E-114D-47A2-82B2-126594AE479BQ35963453-1BE4AAC2-7CFA-41EC-9627-C044A26550B2Q35973450-5B768CC7-F7B6-494B-8303-DA8542497B15Q36090201-4D26AC05-911E-42D2-886B-309FCC6FAAFEQ36477046-D4E3B81D-5CCC-405E-84CE-4FE303AF5BABQ36577985-DADA7190-83D3-40FD-8461-8E856C6D451CQ36585264-82A0D916-34D2-42F4-8ECB-0CC60BAD826EQ36735405-649463E8-E80A-4B00-BB1B-651E22E2D598Q36806592-D6716879-05F6-47A9-AC40-D7585981C7A3Q36896496-1C7DC96C-3841-4880-857A-3C0DAF394112Q36926716-9D9C0C2E-4EB9-4334-997B-088AB01339CAQ36969055-EC1BA57E-8643-4D97-AF88-76F2FC5B4B14Q36979972-81FAEA61-39A0-4B99-9E23-3092B852B034Q37053812-A1179BFF-7B9C-49F5-A5AB-227AB7CA6893Q37053888-4936A867-0076-4302-B765-8F8E6612EFF5Q37091443-09EA84B2-E31E-4F76-ABAD-1BD84433B616
P2860
Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@ast
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@en
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@nl
type
label
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@ast
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@en
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@nl
prefLabel
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@ast
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@en
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@nl
P2093
P1433
P1476
Preclinical Alzheimer disease: ...... 1.5 to 8 years prior to onset.
@en
P2093
Carlson MC
Ratcliff G
P304
P356
10.1212/01.WNL.0000147470.58328.50
P407
P577
2004-12-01T00:00:00Z